Cargando…

Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database

Detalles Bibliográficos
Autores principales: Giabicani, Mikhael, Le Menestrel, Alice, Roux, Olivier, Rautou, Pierre-Emmanuel, Weiss, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482654/
https://www.ncbi.nlm.nih.gov/pubmed/34600975
http://dx.doi.org/10.1016/j.jhep.2021.09.018
_version_ 1784576954241908736
author Giabicani, Mikhael
Le Menestrel, Alice
Roux, Olivier
Rautou, Pierre-Emmanuel
Weiss, Emmanuel
author_facet Giabicani, Mikhael
Le Menestrel, Alice
Roux, Olivier
Rautou, Pierre-Emmanuel
Weiss, Emmanuel
author_sort Giabicani, Mikhael
collection PubMed
description
format Online
Article
Text
id pubmed-8482654
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Association for the Study of the Liver. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84826542021-09-30 Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database Giabicani, Mikhael Le Menestrel, Alice Roux, Olivier Rautou, Pierre-Emmanuel Weiss, Emmanuel J Hepatol Letter to the Editor European Association for the Study of the Liver. Published by Elsevier B.V. 2022-03 2021-09-30 /pmc/articles/PMC8482654/ /pubmed/34600975 http://dx.doi.org/10.1016/j.jhep.2021.09.018 Text en © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Giabicani, Mikhael
Le Menestrel, Alice
Roux, Olivier
Rautou, Pierre-Emmanuel
Weiss, Emmanuel
Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
title Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
title_full Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
title_fullStr Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
title_full_unstemmed Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
title_short Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database
title_sort focus on the decisions to forego life-sustaining therapies during icu stay of patients with cirrhosis and covid-19: a case control study from the prospective covid-icu database
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482654/
https://www.ncbi.nlm.nih.gov/pubmed/34600975
http://dx.doi.org/10.1016/j.jhep.2021.09.018
work_keys_str_mv AT giabicanimikhael focusonthedecisionstoforegolifesustainingtherapiesduringicustayofpatientswithcirrhosisandcovid19acasecontrolstudyfromtheprospectivecovidicudatabase
AT lemenestrelalice focusonthedecisionstoforegolifesustainingtherapiesduringicustayofpatientswithcirrhosisandcovid19acasecontrolstudyfromtheprospectivecovidicudatabase
AT rouxolivier focusonthedecisionstoforegolifesustainingtherapiesduringicustayofpatientswithcirrhosisandcovid19acasecontrolstudyfromtheprospectivecovidicudatabase
AT rautoupierreemmanuel focusonthedecisionstoforegolifesustainingtherapiesduringicustayofpatientswithcirrhosisandcovid19acasecontrolstudyfromtheprospectivecovidicudatabase
AT weissemmanuel focusonthedecisionstoforegolifesustainingtherapiesduringicustayofpatientswithcirrhosisandcovid19acasecontrolstudyfromtheprospectivecovidicudatabase
AT focusonthedecisionstoforegolifesustainingtherapiesduringicustayofpatientswithcirrhosisandcovid19acasecontrolstudyfromtheprospectivecovidicudatabase